Pediatric Cancer Immunotherapy Care Team

Crystal Mackall, MD, is the director of the Stanford Center for Cancer Cell Therapy. She is board certified in pediatric hematology-oncology, pediatrics and internal medicine.

Areas of expertise: cancer immunotherapy, CAR T-cell therapy, pediatric cancers

Catherine Aftandilian, MD, is board certified in pediatric hematology-oncology and pediatrics.

Areas of expertise: acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML), cancer immunotherapy, CAR T-cell therapy

Kara Davis, DO, is board certified in pediatric hematology-oncology and pediatrics.

Areas of expertise: cancer immunotherapy, CAR T-cell therapy, pediatric leukemia, relapsed leukemia

Norman Lacayo, MD, is board certified in pediatric hematology-oncology.

Areas of expertise: acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML), cancer immunotherapy, CAR T-cell therapy

Robbie Majzner, MD, PhD, is board certified in pediatric hematology-oncology and pediatrics.

Areas of expertise: neuroblastoma, solid tumors, cancer immunotherapy, CAR T-cell therapy

Lianna Marks, MD, is board certified in pediatric hematology-oncology and pediatrics.

Areas of expertise: Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, cancer immunotherapy, CAR T-cell therapy

Michelle Monje, MD, PhD, is board certified in neurology and neuro-oncology.

Areas of expertise: neuro-oncology, cancer immunotherapy, CAR T-cell therapy

Sneha Ramakrishna, MD, PhD, is board certified in pediatric hematology-oncology and pediatrics.

Areas of expertise: cancer immunotherapy, CAR T-cell therapy

Liora Schultz, MD, is board certified in pediatric hematology-oncology and pediatrics.

Areas of expertise: cancer immunotherapy, CAR T-cell therapy, acute myeloid leukemia (AML)